PubMed HealthSearch

PubMed · 7017302

Exercise performance in chronic obstructive pulmonary diseases.

Abstract

Patients with chronic obstructive pulmonary diseases demonstrate exercise limitation as a consequence of both an increased ventilatory requirement and a decreased ventilatory capacity. The increased ventilatory requirement arises from the elevated wasted ventilation fraction of each breath (VD/VT) and hypoxemia secondary to ventilation-perfusion mismatching, both of which stimulate minute ventilation of increase. The reduced ventilatory capacity is primarily the result of airflow obstruction, which causes an increased work of breathing. Respiratory muscle fatigue may also play a role in reducing ventilatory capacity. The differentiation of heart failure from chronic obstructive pulmonary diseases as a cause of dyspnea can be accomplished using a variety of noninvasive and invasive techniques during exercise, including measurements of minute ventilation, the expiratory airflow pattern, ventilatory reserve (VEmax/MVV), ventilatory efficiency (VD/VT), arterial blood gases, the anaerobic threshold, heart rate, cardiac output, pulmonary hemodynamics and ventricular ejection fraction. Exercise training of patients with chronic obstructive pulmonary diseases improves exercise intolerance but appears to have little effect on pulmonary function tests, arterial blood gases and pulmonary hemodynamics. Supplemental oxygen during exercise training may be a useful adjunct for improving exercise tolerance in patients with chronic obstructive pulmonary diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H V Brown, K Wasserman. 1981. Exercise performance in chronic obstructive pulmonary diseases.. https://doi.org/10.1016/s0025-7125(16)31512-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Palliation of dyspnea in malignant disease].

Dyspnea is a symptom experienced by more than half of all cancer patients in their terminal illness, and it is thus a severe problem for patients, relatives, and professionals. Dyspnea in a cancer patient may have a non-malignant origin that may be treated causally. If dyspnea is caused directly by the malignant disease, antineoplastic treatment needs to be considered. In case this is not feasible, one must seek to modify the manifestations of illness. When this is not possible, one must relieve the patient's experience of dyspnea. To this end there are a number of possibilities, pharmacological as well as non-pharmacological. Opioids given systemically cause respiratory depression. Unfortunately, this has given rise to an overly cautious attitude when facing the terminal patient with dyspnea. However, other treatment modalities are often exhausted and opioids, if indicated in combination with anxiolytics, do have a palliative effect on dyspnea.

Dyspnea